Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,347 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Adjuvant therapy in colon cancer.
Graham JS, Cassidy J. Graham JS, et al. Among authors: cassidy j. Expert Rev Anticancer Ther. 2012 Jan;12(1):99-109. doi: 10.1586/era.11.189. Expert Rev Anticancer Ther. 2012. PMID: 22149436 Review.
Ring-fencing a budget for cancer drugs: is it fair?
Graham J, Cassidy J, Hughes D, Duerden M. Graham J, et al. Among authors: cassidy j. J R Coll Physicians Edinb. 2011 Sep;41(3):224-8. doi: 10.4997/JRCPE.2011.310. J R Coll Physicians Edinb. 2011. PMID: 21949920
Open-label, non-randomised, inter-individual dose escalation of ZK 304709 with the evaluation of safety, tolerability, pharmacokinetics, oral bioavailability and orientating efficacy after daily administration in patients with advanced cancer (7 d treatment and 14 d recovery).
Graham JS, Plummer R, McCoy C, Kowal K, Wiesinger H, Detjen K, Calvert H, Wiedenmann B, Cassidy J. Graham JS, et al. Among authors: cassidy j. Eur J Cancer. 2008 Oct;44(15):2162-8. doi: 10.1016/j.ejca.2008.06.006. Epub 2008 Jul 22. Eur J Cancer. 2008. PMID: 18653327 Clinical Trial.
Emerging drugs in colorectal cancer.
Scott L, Fraser J, Cassidy J. Scott L, et al. Among authors: cassidy j. Expert Opin Emerg Drugs. 2003 May;8(1):193-202. doi: 10.1517/14728214.8.1.193. Expert Opin Emerg Drugs. 2003. PMID: 14610921 Review.
3-month versus 6-month adjuvant chemotherapy for patients with high-risk stage II and III colorectal cancer: 3-year follow-up of the SCOT non-inferiority RCT.
Iveson T, Boyd KA, Kerr RS, Robles-Zurita J, Saunders MP, Briggs AH, Cassidy J, Hollander NH, Tabernero J, Haydon A, Glimelius B, Harkin A, Allan K, McQueen J, Pearson S, Waterston A, Medley L, Wilson C, Ellis R, Essapen S, Dhadda AS, Harrison M, Falk S, Raouf S, Rees C, Olesen RK, Propper D, Bridgewater J, Azzabi A, Farrugia D, Webb A, Cunningham D, Hickish T, Weaver A, Gollins S, Wasan H, Paul J. Iveson T, et al. Among authors: cassidy j. Health Technol Assess. 2019 Dec;23(64):1-88. doi: 10.3310/hta23640. Health Technol Assess. 2019. PMID: 31852579 Free PMC article. Clinical Trial.
Chemotherapy in metastatic colorectal cancer.
Kelly C, Cassidy J. Kelly C, et al. Among authors: cassidy j. Surg Oncol. 2007 Jul;16(1):65-70. doi: 10.1016/j.suronc.2007.04.006. Epub 2007 May 22. Surg Oncol. 2007. PMID: 17521906 Review.
1,347 results